Long-term follow-up of renal function in patients treated with migalastat for Fabry disease

The effect of migalastat on long-term renal outcomes in enzyme replacement therapy (ERT)–naive and ERT-experienced patients with Fabry disease is not well defined. An integrated posthoc analysis of the phase 3 clinical trials and open-label extension studies was conducted to evaluate long-term chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Bichet, Daniel G., Torra, Roser, Wallace, Eric, Hughes, Derralynn, Giugliani, Roberto, Skuban, Nina, Krusinska, Eva, Feldt-Rasmussen, Ulla, Schiffmann, Raphael, Nicholls, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353473/
https://www.ncbi.nlm.nih.gov/pubmed/34401344
http://dx.doi.org/10.1016/j.ymgmr.2021.100786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353473/
https://www.ncbi.nlm.nih.gov/pubmed/34401344
http://dx.doi.org/10.1016/j.ymgmr.2021.100786

Ejemplares similares